Effectiveness of the Eko Digital Stethoscope in Capturing Infant ECGs
NCT06382207
Summary
When a newborn is diagnosed with tachyarrhythmia, they are generally started on medical therapies, most commonly a beta-blocker, while being observed in an inpatient setting. In most academic institutions, current practice is to provide parental teaching on use of a stethoscope to auscultate their child when there is suspicion for distress, in addition to requiring cardiopulmonary resuscitation (CPR) classes. Fortunately, newer technologies have emerged that allow for capture of cardiac rhythm that may provide a buffer between the infant and the emergency room.
Eligibility
Inclusion Criteria: * Age \<1 year * No previous diagnosis of arrhythmia * Parent/caregiver can provide informed consent * Parent/caregiver can speak and understand simple English Exclusion Criteria: * Age ≥ 1 year * Patient has a pacemaker or implantable cardioverter defibrillator (ICD) * Parent/caregiver is unwilling or unable to provide informed consent * Parent/caregiver is unable to speak and understand English
Conditions2
Locations1 site
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06382207